Celldex Therapeutics, Inc. (CLDX)
27.53
-1.40
(-4.84%)
USD |
NASDAQ |
Oct 16, 16:00
27.53
0.00 (0.00%)
After-Hours: 18:24
Celldex Therapeutics Gross Profit Margin (Quarterly) : -4.00K% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -4.00K% |
| March 31, 2026 | -5.59K% |
| December 31, 2025 | -574.4% |
| September 30, 2025 | |
| June 30, 2025 | -19.59% |
| March 31, 2025 | -24.75% |
| December 31, 2024 | 30.30% |
| September 30, 2024 | 75.37% |
| June 30, 2024 | 68.09% |
| March 31, 2024 | -396.8% |
| December 31, 2023 | 81.63% |
| September 30, 2023 | 49.44% |
| June 30, 2023 | -182.1% |
| March 31, 2023 | 24.92% |
| December 31, 2022 | 58.28% |
| September 30, 2022 | -64.86% |
| June 30, 2022 | -354.6% |
| March 31, 2022 | 0.00% |
| December 31, 2021 | -132.6% |
| September 30, 2021 | 0.00% |
| June 30, 2021 | 0.00% |
| March 31, 2021 | 0.00% |
| December 31, 2020 | 0.00% |
| September 30, 2020 | 0.00% |
| June 30, 2020 | 0.00% |
| Date | Value |
|---|---|
| March 31, 2020 | 0.00% |
| December 31, 2019 | 0.00% |
| September 30, 2019 | 0.00% |
| June 30, 2019 | 0.00% |
| March 31, 2019 | 0.00% |
| December 31, 2018 | 0.00% |
| September 30, 2018 | 0.00% |
| June 30, 2018 | 0.00% |
| March 31, 2018 | 0.00% |
| December 31, 2017 | 0.00% |
| September 30, 2017 | 0.00% |
| June 30, 2017 | 0.00% |
| March 31, 2017 | 0.00% |
| December 31, 2016 | 0.00% |
| September 30, 2016 | 0.00% |
| June 30, 2016 | 0.00% |
| March 31, 2016 | 0.00% |
| December 31, 2015 | 38.58% |
| September 30, 2015 | 0.00% |
| June 30, 2015 | 0.00% |
| March 31, 2015 | 0.00% |
| December 31, 2014 | 40.62% |
| September 30, 2014 | 22.16% |
| June 30, 2014 | -41.22% |
| March 31, 2014 | -100.0% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 79.81% |
| ACADIA Pharmaceuticals, Inc. | 90.81% |
| Alnylam Pharmaceuticals, Inc. | 76.88% |
| Anika Therapeutics, Inc. | 65.15% |
| Savara, Inc. | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -50.91% |
| Return on Assets | -46.71% |
| Return on Invested Capital | -50.66% |
| Profit Margin (Quarterly) | -334.1K% |
| Operating Margin (Quarterly) | -366.5K% |
| Return on Net Operating Assets | -809.5% |